皇家华人

header-logo
GettyImages-609179959-hero
headshot

Laura Michaelis, MD

Chief, Professor

view physician profile

Locations

  • Froedtert Hospital
  • Cancer Center - Froedtert Hospital

Specialties

  • Medical Oncology
  • Hematology

Languages

  • English

Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine

Biography

Laura Michaelis, MD, is a professor of medicine (hematology and oncology) at the 皇家华人, specializing in Acute and Chronic Leukemias, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, Bone Marrow Failure Syndromes, and Myeloid Disorders. She graduated from Harvard Medical School in 2000, then completed her internal medicine residency at Brigham and Women’s Hospital in Boston, MA. She received the Arnold Dunne Award for compassionate care in the practice of medicine during her residency. In 2003, Dr. Michaelis relocated to Chicago, IL, where she completed a hematology/oncology fellowship at the University of Chicago. Dr. Michaelis served as an assistant professor of medicine and program director of the Hematology and Oncology Fellowship Program at Loyola University Medical Center before joining MCW.

Research Interests

Dr. Michaelis's clinical research focuses on Leukemia, Myelodysplastic Syndromes and Myeloproliferative Neoplasms. She serves as director of inpatient services for the division of Hematology/Oncology and was appointed to be one of the Associate Vice Chairs of the Department of Medicine. Dr. Michaelis is board certified in Hematology and Medical Oncology.

Publications

  • (Foy P, Friedman KD, Michaelis LC.) Blood. 2024 Jan 18;143(3):214-223 PMID: 37956435 11/13/2023

  • (Shallis RM, Daver N, Altman JK, Komrokji RS, Pollyea DA, Badar T, Bewersdorf JP, Bhatt VR, de Botton S, de la Fuente Burguera A, Carraway HE, Desai P, Dillon R, Duployez N, El Chaer F, Fathi AT, Freeman SD, Gojo I, Grunwald MR, Jonas BA, Konopleva M, Lin TL, Mannis GN, Mascarenhas J, Michaelis LC, Mims AS, Montesinos P, Pozdnyakova O, Pratz KW, Schuh AC, Sekeres MA, Smith CC, Stahl M, Subklewe M, Uy GL, Voso MT, Walter RB, Wang ES, Zeidner JF, 沤u膷enka A, Zeidan AM.) Lancet Haematol. 2023 Sep;10(9):e767-e776 PMID: 37572683 08/13/2023

  • (Taylor S, Murthy GSG, Runaas L, Michaelis LC, Carlson K, Atallah EL, Abedin SM.) Leuk Res. 2023 Sep;132:107348 PMID: 37423073 SCOPUS ID: 2-s2.0-85164434355 07/10/2023

  • (Moyo TK, Kishtagari A, Villaume MT, McMahon B, Mohan SR, Stopczynski T, Chen SC, Fan R, Huo Y, Moon H, Tang Y, Bejan CA, Childress M, Anderson I, Rawling K, Simons RM, Moncrief A, Caza R, Dugger L, Collins A, Dudley CV, Ferrell PB, Byrne M, Strickland SA, Ayers GD, Landman BA, Mason EF, Mesa RA, Palmer JM, Michaelis LC, Savona MR.) Clin Cancer Res. 2023 Jul 05;29(13):2375-2384 PMID: 37036505 04/11/2023

  • (Assouline S, Michaelis LC, Othus M, Hay AE, Walter RB, Jacoby MA, Schroeder MA, Uy GL, Law LY, Cheema F, Sweet KL, Asch AS, Liu JJ, Moseley AB, Maher T, Kingsbury LL, Fang M, Radich J, Little RF, Erba HP.) Leuk Lymphoma. 2023 Feb;64(2):473-477 PMID: 36517990 PMCID: PMC10652187 12/16/2022

  • (Burstin H, Curry S, Ranney ML, Arora V, Wachler BB, Chou WS, Correa R, Cryer D, Dizon D, Flores EJ, Harmon G, Jain A, Johnson K, Laine C, Leininger L, McMahon G, Michaelis L, Minhas R, Mularski R, Oldham J, Padman R, Pinnock C, Rivera J, Southwell B, Villarruel A, Wallace K.) NAM Perspect. 2023;2023 PMID: 37916063 PMCID: PMC10617996 11/02/2023

  • (Othus M, Thomas I, Wang X, Ariti C, Mehta P, Sydenham M, Hills RK, Burnett AK, Nand S, Assouline S, Michaelis LC, Erba HP, Russell N, Kerr KF, Walter RB, Dennis M.) Leuk Lymphoma. 2023 Jan;64(1):250-252 PMID: 36226777 PMCID: PMC10662133 10/14/2022

  • (Abedin SM, Badar T, Gauger K, Michaelis LC, Runaas L, Carlson KS, Murthy GG, Atallah E.) Leuk Res. 2022 Dec;123:106984 PMID: 36401944 SCOPUS ID: 2-s2.0-85141943453 11/20/2022

  • (Mohan M, Nagavally S, Shah N NN, Michaelis L, Chhabra S, Souza AD, Abedin S, Runaas L, Guru Murthy GS, Longo W, Hamadani M, Dhakal B, Hari P, Fenske TS.) Clin Lymphoma Myeloma Leuk. 2022 Jul;22(7):e495-e497 PMID: 35148976 PMCID: PMC8767926 SCOPUS ID: 2-s2.0-85132179962 02/13/2022

  • (Dong A, Pan X, Lin CW, Huang YW, Krause H, Pan P, Baim A, Thomas MJ, Chen X, Yu J, Michaelis L, Liu P, Wang LS, Atallah E.) J Cancer Prev. 2022 Jun 30;27(2):129-138 PMID: 35864858 PMCID: PMC9271408 07/23/2022

  • (Berce PC, Cardwell L, Essenmacher AN, Michaelis LC, Wanat KA.) JAAD Case Rep. 2022 Apr;22:110-113 PMID: 35372654 PMCID: PMC8971330 04/05/2022

  • (Corrao K, Rezwan S, Atallah E, Michaelis LC, Runaas L, Harrington AM, Abedin S.) Leuk Res Rep. 2022;17:100329 PMID: 35651540 PMCID: PMC9150024 SCOPUS ID: 2-s2.0-85131561638 06/03/2022

Publications of from the

© 2024 皇家华人.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.